DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 2 USDMF, 1 NDC API

2 API Suppliers
2 USDMF
1 NDC API

DIGITAL CONTENT

1 NEWS #PharmaBuzz

media
1 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 15060-55-6, Tiomolibdate diammonium, Ammonium tetrathiomolybdate(vi), Molybdate(2-), tetrathioxo-, diammonium, (t-4)-, Ammonium thiomolybdate, Ammonium molybdenum sulfide

Molecular Formula

H₁₀MoN₂S₄

Molecular Weight

262.3 g/mol

InChI Key

ZKKLPDLKUGTPME-UHFFFAOYSA-N

FDA UNII

4V6I63LW1E

Tiomolibdate Diammonium is an ammonium salt with potential antiangiogenic and antitumor activities. Tetrathiomolybdate has been found to deplete systemic copper reserves through an unknown mechanism. This agent has been shown to inhibit the activities of cuproenzymes, including superoxide dismutase 1 (SOD1) and cytochrome c oxidase (COX), which may contribute to its antiangiogenic and antitumor effects.

1 2D Structure

Ammonium Tetrathiomolybdate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

diazanium;bis(sulfanylidene)molybdenum;sulfanide

2.1.2 InChI

InChI=1S/Mo.2H3N.2H2S.2S/h;2*1H3;2*1H2;;

2.1.3 InChI Key

ZKKLPDLKUGTPME-UHFFFAOYSA-N

2.1.4 Canonical SMILES

[NH4+].[NH4+].[SH-].[SH-].S=[Mo]=S

2.2 Other Identifiers

2.2.1 UNII

4V6I63LW1E

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Atn-224

2. Tetrathiomolybdate

3. Tetrathiomolybdate Bis-choline Salt

4. Tetrathiomolybdate, Dipotassium Salt

5. Tetrathiomolybdate, Disodium Salt

6. Thiomolybdate

7. Ttm Cpd

2.3.2 Depositor-Supplied Synonyms

1. 15060-55-6

2. Tiomolibdate Diammonium

3. Ammonium Tetrathiomolybdate(vi)

4. Molybdate(2-), Tetrathioxo-, Diammonium, (t-4)-

5. Ammonium Thiomolybdate

6. Ammonium Molybdenum Sulfide

7. Coprexa

8. Tiomolibdate Diammonium [usan]

9. Mfcd00136013

10. Attm

11. Att-m

12. 4v6i63lw1e

13. Diammonium Tetrathiomolybdate

14. Nsc-286644

15. Nsc-714598

16. Ammonium Tetrathiomolybdate [mi]

17. Ammonium Tetrathiomolybdate [who-dd]

18. Diazanium;bis(sulfanylidene)molybdenum;sulfanide

19. Ammonium Molybdenum Sulfide ((nh4)2mos4)

20. J-008719

21. Q4747310

22. Molybdate(2-), Tetrathioxo-, Ammonium (1:2), (t-4)-

23. Ammonium Tetrathiomolybdate(vi), 99% (99.99%-mo) Puratrem

2.4 Create Date

2007-02-09

3 Chemical and Physical Properties

Molecular Formula	H₁₀MoN₂S₄
Molecular Weight	262.3 g/mol
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	0
Exact Mass	263.878087 g/mol
Monoisotopic Mass	263.878087 g/mol
Topological Polar Surface Area	68.2 Å²
Heavy Atom Count	7
Formal Charge	0
Complexity	19.1
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	5

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Angiogenesis Inhibitors

Agents and endogenous substances that antagonize or inhibit the development of new blood vessels. (See all compounds classified as Angiogenesis Inhibitors.)

Chelating Agents

Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)

Enzyme Inhibitors

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)

API SUPPLIERS